{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:50:52Z","timestamp":1782906652604,"version":"3.54.5"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1097\/md.0000000000004206","type":"journal-article","created":{"date-parts":[[2016,9,15]],"date-time":"2016-09-15T08:42:19Z","timestamp":1473928939000},"page":"e4206","source":"Crossref","is-referenced-by-count":20,"title":["Is cerebral glucose metabolism related to blood\u2013brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease?"],"prefix":"10.1097","volume":"95","author":[{"given":"Agostino","family":"Chiaravalloti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fiorentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursini","family":"Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Belli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Toniolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Di Pietro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orazio","family":"Schillaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210302","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"R2-2-20210302","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of Alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol Aging"},{"key":"R3-2-20210302","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"R4-2-20210302","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.neurol.2013.07.016","article-title":"Alzheimer disease: from biomarkers to diagnosis","volume":"169","author":"Dubois","year":"2013","journal-title":"Rev Neurol"},{"key":"R5-2-20210302","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2217\/bmm.09.65","article-title":"Alzheimer's disease and CSF biomarkers: key challenges for broad clinical applications","volume":"3","author":"Mattsson","year":"2009","journal-title":"Biomark Med"},{"key":"R6-2-20210302","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365517709091496","article-title":"Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values","volume":"37","author":"Tibbling","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"R7-2-20210302","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000116919","article-title":"Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18\u201388 years of age","volume":"33","author":"Blennow","year":"1993","journal-title":"Eur Neurol"},{"key":"R8-2-20210302","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1600-0404.2007.00823.x","article-title":"The integrity of the blood-brain barrier in Alzheimer's disease","volume":"115","author":"Algotsson","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"R9-2-20210302","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1212\/01.wnl.0000262031.18018.1a","article-title":"Blood-brain barrier impairment in Alzheimer disease: stability and functional significance","volume":"68","author":"Bowman","year":"2007","journal-title":"Neurology"},{"key":"R10-2-20210302","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-2010-1313","article-title":"Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics","volume":"19","author":"Zimmermann","year":"2010","journal-title":"J Alzheimer Dis"},{"key":"R11-2-20210302","first-page":"176","article-title":"IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis","volume":"62","author":"Henriksson","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"R12-2-20210302","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain"},{"key":"R13-2-20210302","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/aws105","article-title":"Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis","volume":"135","author":"Elliott","year":"2012","journal-title":"Brain"},{"key":"R14-2-20210302","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fneur.2014.00027","article-title":"Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?","volume":"5","author":"Bonnan","year":"2014","journal-title":"Front Neurol"},{"key":"R15-2-20210302","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1871527315666160202125914","article-title":"Inflammatory mechanisms and oxidative stress as key factors responsible for progression of neurodegeneration: role of brain innate immune system","volume":"15","author":"Leszek","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R16-2-20210302","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nicl.2014.11.007","article-title":"Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study","volume":"7","author":"Pagani","year":"2015","journal-title":"NeuroImage Clin"},{"key":"R17-2-20210302","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3233\/JAD-142229","article-title":"Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project","volume":"44","author":"Morbelli","year":"2015","journal-title":"J Alzheimer Dis"},{"key":"R18-2-20210302","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.66.2.184","article-title":"Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia","volume":"66","author":"Varma","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R19-2-20210302","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/j.clinph.2004.04.022","article-title":"Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia","volume":"115","author":"Pierantozzi","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"R20-2-20210302","first-page":"183","article-title":"F-FDG PET\/MR in herpes simplex virus encephalitis: a case study","volume":"2","author":"Schillaci","year":"2014","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"R21-2-20210302","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1371\/journal.pone.0057596","article-title":"Early and phasic cortical metabolic changes in vestibular neuritis onset","volume":"8","author":"Alessandrini","year":"2013","journal-title":"PLoS One"},{"key":"R22-2-20210302","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u2018Mini-mental state\u2019. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R23-2-20210302","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.acn.2006.06.010","article-title":"Test performance and classification statistics for the Rey Auditory Verbal Learning Test in selected clinical samples","volume":"21","author":"Schoenberg","year":"2006","journal-title":"Arch Clin Neuropsychol"},{"key":"R24-2-20210302","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nprot.2006.115","article-title":"Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test","volume":"1","author":"Shin","year":"2006","journal-title":"Nat Protoc"},{"key":"R25-2-20210302","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuropsychologia.2004.02.001","article-title":"Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis","volume":"42","author":"Henry","year":"2004","journal-title":"Neuropsychologia"},{"key":"R26-2-20210302","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1073191112446655","article-title":"Development of abbreviated nine-item forms of the Raven's standard progressive matrices test","volume":"19","author":"Bilker","year":"2012","journal-title":"Assessment"},{"key":"R27-2-20210302","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/MNM.0000000000000272","article-title":"Functional correlates of t-Tau, p-Tau and Abeta(1)(-)(4)(2) amyloid cerebrospinal fluid levels in Alzheimer's disease: a (1)(8)F-FDG PET\/CT study","volume":"36","author":"Chiaravalloti","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R28-2-20210302","first-page":"246412","article-title":"Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies","volume":"2011","author":"Teunissen","year":"2011","journal-title":"Mult Scler Int"},{"key":"R29-2-20210302","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/scan\/nsp053","article-title":"The principled control of false positives in neuroimaging","volume":"4","author":"Bennett","year":"2009","journal-title":"Soc Cogn Affect Neurosci"},{"key":"R30-2-20210302","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/nimg.1999.0459","article-title":"Three-dimensional MRI atlas of the human cerebellum in proportional stereotaxic space","volume":"10","author":"Schmahmann","year":"1999","journal-title":"NeuroImage"},{"key":"R31-2-20210302","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1006\/nimg.2002.1259","article-title":"Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake","volume":"17","author":"Soonawala","year":"2002","journal-title":"NeuroImage"},{"key":"R32-2-20210302","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/j.1582-4934.2008.00434.x","article-title":"A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer's disease brain","volume":"13","author":"Ryu","year":"2009","journal-title":"J Cell Mol Med"},{"key":"R33-2-20210302","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.neurobiolaging.2013.12.026","article-title":"Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP\/PS1 mice","volume":"35","author":"Minogue","year":"2014","journal-title":"Neurobiol Aging"},{"key":"R34-2-20210302","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.6102-11.2012","article-title":"Abeta(1)(-)(4)(2)-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca(2)(+)-calcineurin signaling","volume":"32","author":"Kook","year":"2012","journal-title":"J Neurosci"},{"key":"R35-2-20210302","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3233\/JAD-122374","article-title":"Functional and molecular characterization of the effect of amyloid-beta42 on an in vitro epithelial barrier model","volume":"38","author":"Gheorghiu","year":"2014","journal-title":"J Alzheimer Dis"},{"key":"R36-2-20210302","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/87565640701190841","article-title":"Superior temporal gyrus, language function, and autism","volume":"31","author":"Bigler","year":"2007","journal-title":"Develop Neuropsychol"},{"key":"R37-2-20210302","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.neuroimage.2009.01.009","article-title":"Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo","volume":"45","author":"Pievani","year":"2009","journal-title":"NeuroImage"},{"key":"R38-2-20210302","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.neuroimage.2008.10.003","article-title":"Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease","volume":"44","author":"Filippini","year":"2009","journal-title":"NeuroImage"},{"key":"R39-2-20210302","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jmri.20669","article-title":"Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls","volume":"24","author":"Wang","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"R40-2-20210302","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pscychresns.2008.04.003","article-title":"Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study","volume":"171","author":"Starr","year":"2009","journal-title":"Psychiatry Res"},{"key":"R41-2-20210302","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"R42-2-20210302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1987.1","article-title":"Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography","volume":"7","author":"Schlageter","year":"1987","journal-title":"J Cereb Blood Flow Metab"},{"key":"R43-2-20210302","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000017248","article-title":"White matter lesions in dementia: an MRI study on blood-brain barrier dysfunction","volume":"11","author":"Bronge","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"R44-2-20210302","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.50.4.966","article-title":"A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia","volume":"50","author":"Skoog","year":"1998","journal-title":"Neurology"},{"key":"R45-2-20210302","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00002093-199903000-00002","article-title":"Oligoclonal bands and blood\u2013cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis","volume":"13","author":"Hampel","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R46-2-20210302","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002093-199408010-00006","article-title":"Central nervous system IgG synthesis rates in Alzheimer disease: possible differences in early-onset and late-onset subgroups","volume":"8","author":"Small","year":"1994","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"R47-2-20210302","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0924-977X(90)90017-5","article-title":"Intrathecal synthesis of immunoglobulins in patients with Alzheimer's disease","volume":"1","author":"Blennow","year":"1990","journal-title":"Eur Neuropsychopharmacol"},{"key":"R48-2-20210302","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2012.08.001","article-title":"Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament","volume":"252","author":"Bartos","year":"2012","journal-title":"J Neuroimmunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:28:46Z","timestamp":1620959326000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201609130-00002"}},"subtitle":["A 18F-FDG PET\/CT study"],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":48,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004206","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}